This review focuses on the evidence for neurotherapeutics for attention deficit/hyperactivity
disorder (ADHD). EEG-neurofeedback has been tested for about 45 years, with the latest …

Attention deficit hyperactivity disorder (ADHD) is a common condition with a high societal
burden. The present guidelines summarise current literature, generating expert consensus …

Objective To develop treatment guidelines for attention-deficit/hyperactivity disorder (ADHD)
based upon consensus among physicians and psychologists, particularly concerning …

Attention-deficit/hyperactivity disorder (ADHD) is a common and impairing disorder affecting
children, adolescents, and adults. Several treatment strategies are available that can …

A substantial body of evidence has supported the efficacy and safety of pharmacological
treatment available for attention deficit/hyperactivity disorder (ADHD). There is increasing …

Attention-deficit/hyperactivity disorder (ADHD) is a highly prevalent disorder of childhood
and adulthood, with a considerable impact on public health. There is a substantial …

Attention-deficit/hyperactivity disorder (ADHD) is characterised by a persistent and impairing
pattern of inattention and/or hyperactivity/impulsivity and it is one of the most common …

Attention-deficit/hyperactivity disorder (ADHD) is one of the most common
neurodevelopmental disorders having a high influence on social interactions. The number of …

Background Attention deficit hyperactivity disorder (ADHD) is a developmental condition
characterised by symptoms of inattention, hyperactivity and impulsivity, along with deficits in …

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that
manifests in childhood and can persist into adolescence and adulthood. Impairments …